|NOX4-dependent ROS production by stromal mammary cells modulates epithelial MCF-7 cell migration.|
|Jump to Full Text|
|PMID: 20717118 Owner: NLM Status: MEDLINE|
|BACKGROUND: The influence of the stromal microenvironment on the progression of epithelial cancers has been demonstrated. Unravelling the mechanisms by which stromal cells affect epithelial behaviour will contribute in understanding cellular malignancy. It has been proposed that redox environment has a role in the acquisition of malignancy. In this work, we studied the influence of epithelial cells on the stromal redox status and the consequence of this phenomenon on MCF-7 cell motility.
METHODS: We analysed in a co-culture system, the effect of RMF-EG mammary stromal cells on the migratory capacity of MCF-7 cell line. To test whether the NOX-dependent stromal redox environment influences the epithelial migratory behaviour, we knocked down the expression of NOX4 using siRNA strategy. The effect of TGF-β1 on NOX4 expression and activity was analysed by qPCR, and intracellular ROS production was measured by a fluorescent method.
RESULTS: Migration of MCF-7 breast epithelial cells was stimulated when co-cultured with RMF-EG cells. This effect depends on stromal NOX4 expression that, in turn, is enhanced by epithelial soluble factors. Pre-treatment of stromal cells with TGF-β1 enhanced this migratory stimulus by elevating NOX4 expression and intracellular ROS production. TGF-β1 seems to be a major component of the epithelial soluble factors that stimulate NOX4 expression.
CONCLUSIONS: Our results have identified that an increased stromal oxidative status, mainly provided by an elevated NOX4 expression, is a permissive element in the acquisition of epithelial migratory properties. The capacity of stromal cells to modify their intracellular ROS production, and accordingly, to increase epithelial motility, seems to depend on epithelial soluble factors among which TGF-β1 have a decisive role.
|N Tobar; J Guerrero; P C Smith; J Martínez|
Related Documents :
|9878518 - Analysis of telomerase expression and proliferative activity in the different layers of...
16481008 - Prunella stica inhibits the proliferation but not the prostaglandin production of ishik...
14605098 - Estrogen receptor functional activity changes during differentiation of mammary epithel...
10821498 - Molecular evidence that the stromal and epithelial cells in pleomorphic adenomas of sal...
21083418 - Hair follicle-derived smooth muscle cells and small intestinal submucosa for engineerin...
22467858 - Rac1 acts in conjunction with nedd4 and dishevelled-1 to promote maturation of cell-cel...
|Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2010-08-17|
|Title: British journal of cancer Volume: 103 ISSN: 1532-1827 ISO Abbreviation: Br. J. Cancer Publication Date: 2010 Sep|
|Created Date: 2010-09-29 Completed Date: 2010-10-25 Revised Date: 2013-05-28|
Medline Journal Info:
|Nlm Unique ID: 0370635 Medline TA: Br J Cancer Country: England|
|Languages: eng Pagination: 1040-7 Citation Subset: IM|
|Cellular and Molecular Biology Laboratory, INTA, Universidad de Chile Casilla 138, Santiago 11, Chile.|
|APA/MLA Format Download EndNote Download BibTex|
Breast Neoplasms / pathology*
Cell Line, Tumor
Epithelial Cells / physiology*
NADPH Oxidase / pharmacology*
Reactive Oxygen Species / metabolism*
Stromal Cells / metabolism*, physiology
Transforming Growth Factor beta1 / pharmacology
|0/Reactive Oxygen Species; 0/Transforming Growth Factor beta1; EC 1.6.3.-/NOX4 protein, human; EC 126.96.36.199/NADPH Oxidase|
Journal ID (nlm-ta): Br J Cancer
Publisher: Nature Publishing Group
Copyright © 2010 Cancer Research UK
Received Day: 27 Month: 04 Year: 2010
Revision Received Day: 13 Month: 07 Year: 2010
Accepted Day: 16 Month: 07 Year: 2010
Print publication date: Day: 28 Month: 09 Year: 2010
Electronic publication date: Day: 17 Month: 08 Year: 2010
Volume: 103 Issue: 7
First Page: 1040 Last Page: 1047
Publisher Item Identifier: 6605847
PubMed Id: 20717118
|NOX4-dependent ROS production by stromal mammary cells modulates epithelial MCF-7 cell migration Alternate Title:Stromal NOX4 modulates MCF-7 migration|
|P C Smith2|
1Cellular and Molecular Biology Laboratory, INTA, Universidad de Chile Casilla 138, Santiago 11, Chile
2Laboratory of Periodontal Physiology, Dentistry Academic Unit, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile
Convincing experimental data support the involvement of cellular stroma in carcinoma progression (De Wever and Mareel, 2003). Particularly, there is strong evidence supporting the role of the stromal cells in breast cancer growth and development (Radisky and Radisky, 2007). Available data suggest that carcinoma and stromal cells maintain an active dialogue with functionally reciprocal consequences. In that way, soluble stromal products are able to modify the invasive potential of carcinoma cells, and epithelial factors are responsible for the development of a ‘stromal response' that in some tumours, such as those of breast, stomach and pancreas, is termed desmoplasia (Elenbaas and Weinberg, 2001).
Among the variety of cell types that constitute the tumoral microenvironment, fibroblasts have been mentioned as an important component. Under the stimuli of tumour cells, fibroblasts are able to acquire some functional properties that confer them a ‘reactive' phenotype, becoming what is termed as carcinoma-associated fibroblasts (CAFs) (Egeblad et al, 2005). Considerable experimental work sustains that CAFs produce tumour-promoting and angiogenic factors along with chemokines that contribute to the recruitment of bone marrow-derived cells (Ostman and Augsten, 2009).
An emerging issue in the carcinogenesis field has arisen from studies that revealed that a chronic inflammatory condition predisposes the epithelial component of tissues to develop a tumour (Coussens and Werb, 2002). A key element in this process is the establishment of an oxidative stress at the tissue level that generates an increase in reactive oxygen species (ROS) phenomenon that, as has been previously demonstrated, contributes to carcinoma malignancy (Blanchetot and Boonstra, 2008). Some previous observations indicate that ROS, acting as secondary messengers, have a role in the regulation of cell proliferation, which is crucial in tumour cells that produce elevated ROS levels (Szatrowski and Nathan, 1991).
The cellular oxidative stress that contributes to the aetiology of cancer is produced by an endogenous generation of ROS that arises from two main sources: the mitochondria and the NAD(P)H oxidase (NOX) system (Dröge, 2002). In non-phagocytic cells, the NOX family is a key component of the so-called ‘redox signalling system' that regulates many cellular responses by modulating the intracellular ROS content. The alteration in the cellular oxidative status generates changes in processes such as cell migration and growth (Ushio-Fukai and Nakamura, 2008). For example, it has been demonstrated that the NOX-dependent basal oxidative stress of both prostatic cell lines and normal epithelial cells is directly associated with the expression of the aggressive phenotype (Kumar et al, 2008). On the other hand, it has also been demonstrated that NOX1 stimulates cell proliferation, activating the cell cycle by reducing the requirement for growth factors to maintain the expression of cyclin D1 and stimulating the transcriptional activation of Fos family genes during the immediate early gene response (Ranjan et al, 2006).
In this study we investigate the influence that a human mammary fibroblast cell line (RMF-EG cells) exerts on the migratory behaviour of the weakly invasive human mammary cell line MCF-7. Using a co-culture system as a model of stromal–epithelial interaction, we analysed the role of the NOX-dependent oxidative intracellular status of RMF-EG cells on the migration of MCF-7 cells. In addition, we studied the role of TGF-β1, a growth factor that is highly expressed in tumour cells, in the maintenance of a pro-oxidative environment and the consequent production of soluble factors that stimulate epithelial migration.
Human recombinant TGFβ1 was purchased from R&D Systems (Minneapolis, MN, USA). 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA), N-acetylcysteine (NAC), diphenyleneiodonium chloride (DPI) and bovine catalase were from Sigma (St Louis, MO, USA). SB431542 inhibitor was from TOCRIS Bioscience (Business Park Ellisville, MO, USA).
Human mammary cell lines MCF-7, MCF-10 and MDA MB-231 were obtained from the ATCC (Manassas, VA, USA) and were cultured in DMEM/F12 medium (Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) (Hyclone, Logan, UT, USA) and maintained in a humidified atmosphere of 37°C, 5% CO2. RMF-EG stromal cells were kindly provided by Dr Charlotte Kuperwasser (Tufts University, Boston, MA, USA) and cultured in DMEM medium (Invitrogen) supplemented with 10% FBS (Kuperwasser et al, 2004). MCF7 cells were transiently transfected with 2 μg ml–1 of the plasmid encoding for the dominant-negative form of TGF-β receptor I (dnTβRI) or pcDNA3.1 (empty vector), using Lipofectamine 2000 reagent according to the manufacturer's protocol (Invitrogen). The 48 h post-transfected cells were used to stimulate migration of MCF-7 cells.
MCF-7 and MCF-10 cell migration was studied using a 6.5-mm Transwell chamber with a pore size of 8 μm (Corning, Corning, NY, USA). The Transwell membranes were coated with 10% FBS in culture media for 2 h at 37°C only on the underside. MCF-7 and MCF-10 cells (6 × 104) were re-suspended in serum-free medium and seeded on the upper compartment of the chamber. RMF-EG cells that were untreated or pre-treated with DPI or NAC were used to induce migration of MCF-7 cells. For this, 4 × 104 RMF-EG cells, suspended in culture media enriched with 1% FBS, were incubated with 5 μ of DPI or 1 m NAC for 16 h and were then washed with 1 × PBS twice, before placing the insert with migrating MCF-7 cells. Additionally, we evaluated the migratory ability of MCF-7 cells that were stimulated by RMF-EG cells pre-treated 16 h with 10 ng ml–1 of TGF-β1 in the presence or absence of 5 μ of DPI (added 30 min before) and RMF-EG cells transfected with the dominant-negative version of dnTβRI. In this case, the lower chamber of the Transwell was filled with medium enriched with 1% FBS. Migration was allowed to occur for 24 h, after which cells of the upper membrane surface were removed by a cotton swab and repeatedly washed with PBS. In migration experiments performed in the presence of catalase, 3000 IU of bovine catalase (Sigma) was added to the lower chamber of the Transwell. Migration values were determined by counting five ( × 20) fields per chamber after fixing the membrane in methanol and staining the migratory cells on the lower side of the membrane with 0.2% crystal violet (Tobar et al, 2008).
We also performed Transwell experiments using a 0.4-μm pore membrane (24 mm diameter) bicameral system that prevents cell migration. RMF-EG cells (5 × 105) were cultured in the lower well and MCF-7 cells (5 × 105) in the upper chamber of the Transwell in serum-free media for 24 h. Both cell types were lysed with TRIzol to extract RNA.
For transient siRNA transfection, RMF-EG cells at 70% confluence were transfected using TransIT-siQuest (Mirus, Madison, WI, USA) at 1 : 600 dilutions in complete medium, according to the manufacturer's recommendation, with a final siRNA concentration of 50 n for 72 h. The oligos used to inhibit NOX4 expression were obtained from Santa Cruz (sc-41586, Santa Cruz, CA, USA), which is referred in the text as siRNA NOX4-I, and from Integrated DNA Technologies (Coralville, IA, USA) with the following sequences: 5′-GCCUCUACAUAUGCAAUAA-3′ and is referred to as NOX4-II (Carmona-Cuenca et al, 2008). As a control unsilenced siRNA, the sc 37007 oligo from Santa Cruz was used.
The oxidation-sensitive fluorescent probe H2DCFDA was used to analyse the total intracellular content of ROS. In a representative assay, RMF-EG cells were incubated with 5.0 μ H2DCFDA in serum- and phenol red-free medium (Gibco Invitrogene, Carlsbad, CA, USA) for 30 min at 37°C. Cells were then washed and lysed with 0.1 N NaOH, and fluorescence was monitored using a microplate fluorometer (Spectra MAX, Gemini EM; Molecular Devices, Silicon Valley, CA, USA) with wavelengths of 480 and 530 nm for excitation and emission, respectively (Benhar et al, 2001). In experiments in which NOX-dependent ROS production was blocked, cells were transfected with NOX4 siRNA 72 h previous to ROS determination. In experiments in which the intracellular content of ROS was exogenously modulated, RMF-EG cells were pre-treated 24 h with 1–10 ng ml–1 of TGF-β1 before fluorometric determination of ROS.
Serum-starved RMF-EG cells (106 cells per dish) were treated with TGF-β1 (1–10 ng ml–1) for 24 h or transfected with siRNA for NOX4. Afterwards, total protein extracts were obtained using a lysis buffer containing 30 m Tris-HCl pH 7.5, 5.0 m EDTA, 150 m NaCl, 1% Triton X-100, 0.5% sodium deoxycolate, 0.1% SDS and 10% glycerol, 2 m PMSF, 2 μg ml–1 pepstatin, 2 μg ml–1 leupeptin and 1 m orthovanadate at 4°C. Pellets were incubated for 1 h in lysis buffer at 4°C, sonicated for 5 s, boiled for 5 min and centrifuged at 16 500 g for 10 min at 4°C. The antibodies used were: mouse anti-β-actin (clone AC-15; Sigma) and anti-NOX4 rabbit polyclonal antibody (ab 41886; Abcam, Cambridge, MA, USA). Equal amounts of protein from different treatments were resolved by 10% SDS–PAGE and analysed by immunoblotting using the ECL chemiluminiscence detection kit (Amersham, Arlington Heights, FL, USA).
Total RNA was isolated with Trizol (GIBCO, Carlsbad, CA, USA) from RMF-EG and control cells. Complementary DNA was generated by M-MLV reverse transcriptase (Promega, Madison, WI, USA) using oligo (dT) (Promega) as primer and 1.5 μg of total RNA. Semiquantitative PCR reactions were performed using the following human-specific primers:
NOX1, forward 5′-GTACAAATTCCAGTGTGCAGACCAC-3′ and reverse 5′-CAGACTGGAATATCGGTGACAGCA-3′, PCR product size 397 and 250 bp, corresponding to the large and short forms of the molecule; NOX2, forward 5′-GTCACACCCTTCGCATCCATTCTCAAGTCAGT-3′ and reverse 5′CTGAGACTCATCCCAGCCAGTGAGGTAG-3′, PCR product size 225 bp; NOX4, forward 5′-TAGATACCCACCCTCCC-3′ and reverse 5′-GACTTATGACCGAAATGA-3′, PCR product size 294 bp; NOX5, forward 5′-ATCAAGCGGCCCCCTTTTTTCAC-3′ and reverse 5′-CTCATTGTCACACTCCTCGACAGC-3′, PCR product size 239 bp; α-Sma, forward 5′-GCAGCCCAGCCAAGCACTGTCAGGAAT-3′ and reverse 5′-AGCCCAGAGCCATTGTCACACACCAAGG-3′, PCR product size 674 bp; QNOX4, forward 5′-TAGATACCCACCCTCCCG-3′ and reverse 5′-TGGGCTCTTCCATACAAATC-3′, QPCR product size: 168 bp; 18S, forward 5′-GGACACGGACAGGATTGACA-3′ and reverse 5′-GGACATCTAAGGGCATCACAG-3′, PCR product size 240 bp.
The expression of 18S was analysed as a loading control. PCR products were subjected to electrophoresis on a 1.5% agarose gel, and DNA was visualised by ethidium bromide staining. Quantification of bands was determined using KODAK Molecular Imaging Software Version Upgrade 4.0 (Kodak, Rochester, NY, USA). To identify the expression of the different isoforms of NOX in RMF-EG cells, RT–PCR was run for 38 cycles. To test the effect of epithelial factors on NOX4 and NOX5 expression in co-culture, RT–PCR was performed at the linear zone of the saturation curve, that is, 32 cycles for both isoforms.
Quantitative PCR was performed with the real-time PCR system, LightCycler (Roche, Basel, Switzerland). Each reaction was conducted in glass capillaries with 50 ng of cDNA, in a final volume of 10 μl. The PCR mixture contained LC FastStart DNA Master SYBR Green I (Roche Diagnostics, Basel, Switzerland), 3 m MgCl2 and 0.3 pmol of each primer (forward and reverse). Fluorescence was analysed using LightCycler Analysis Software. The crossing point for each reaction was determined using the Fit point algorithm and manual baseline adjustment. Quantification was determined using a relative standard curve method with different amounts of a reference standard DNA generated from PCR amplicon for each target gene and expressed as copies per μl. The template for the gene-specific standard curve was generated via conventional PCR and purification was performed using a Concert Rapid Gel extraction system (Gibco Invitrogene). The amount of transcript for each gene of interest was normalised against the 18S transcripts. The experiments were performed three times and in duplicate from three different RNA samples.
To evaluate the inductive role of RMF-EG mammary stromal cells on MCF-7 migration, we established an 8-μm pore size Transwell system, plating 4 × 104 RMF-EG cells in the lower chamber surface and 6 × 104 MCF-7 in the insert, according to the protocol described in the Materials and Methods. To analyse the involvement of stromal NOX-dependent ROS production on MCF-7 cells migration, we pre-incubated RMF-EG monolayer overnight with 5 μ of the flavoprotein inhibitor DPI. To analyse the participation of ROS, independent of its intracellular source, we pre-incubated another group of RMF-EG stromal cells with 1 m NAC, a potent antioxidant molecule with a broad spectrum of action. After this, cells were washed and the insert containing MCF-7 cells was installed, thus initiating the migration assay. As Figure 1A shows, co-culture of epithelial cells with intact stromal cells induced a three-fold increase in cell migration. Pre-treatment of RMF-EG cells with DPI or NAC abrogated this effect almost completely. To assess the specificity of the stromal effect on tumour cells, we performed a migratory assay in the same experimental conditions described above, but using the MCF-10 cell line, a non-tumour homologue of MCF-7 cells line. As Figure 1A shows, migration of MCF-10 cells was not modified by co-culture conditions or the presence of stromal cells that were pre-treated with antioxidant molecules. From the results on MCF-7 cells, two possible explanations arise: on one hand, under the stimulus of soluble epithelial factors, RMF-EG cells generate a soluble form of ROS that stimulates migration of MCF-7 cells and , on the other hand, the epithelial-induced changes in stromal redox status induces the expression of an unknown soluble factor that modulates MCF-7 migration. To evaluate these two possibilities, we performed migration assays in which 3000 IU of bovine catalase was included in the lower well of the Transwell. As Figure 1B shows, either in the presence or in the absence of RMF-EG cells, exogenous catalase does not affect the basal or the stimulated MCF-7 migration, suggesting that the generation of a redox-dependent migratory soluble factor from RMF-EG origin is the more plausible possibility.
The ability of DPI to inhibit the RMF-EG-dependent MCF-7 cell migration strongly suggests that some of the isoforms described for NOX in these stromal cells were having a role is this paracrine stimulus. Therefore, using specific primers, we analysed which isoforms of the NOX system are expressed in RMF-EG cells. RT–PCR analysis of mRNA extracted from these cells shows that they expressed predominantly the NOX4 and NOX5 isoforms (Figure 2A). As a primer control, mRNAs from different cell lines that express specific NOX were used. NOX3 was not included in this analysis because it has been demonstrated that it is expressed mainly in fetal tissues (Cheng et al, 2001).
Once we identified that NOX4 and NOX5 were the predominant isoforms for NOX in RMF-EG cells, we analysed whether the expression of mRNA for these isoforms was modified by soluble factors generated by MCF-7 cells. To test this, RMF-EG cells were seeded in Transwell co-culture inserts (impermeable to cell migration) and co-cultured for the same period used in the migratory assay (24 h). In addition, to assess if the contact with mammary cell-produced factors constitutes a stimulus for myofibroblast differentiation, we analysed in RMF-EG cells the expression of α-Sma, a distinctive marker of this phenotype. As Figure 2B and C shows, RMF-EG cells co-cultured with MCF-7 mammary cells express almost four-fold NOX4 mRNA compared with untreated cells. The MCF-7 stimulus enhanced two-fold the α-Sma expression, suggesting that the postulated epithelial soluble factors may also constitute a stimulus for myofibroblast differentiation. No stimulatory effect was observed in the case of NOX5.
To study the possible role of NOX4 in the RMF-EG-mediated stimulus on MCF-7 migration, we used a targeted knockdown by siRNA approach to downregulate the enzyme expression. As Figure 3A shows, RMF-EG cells transiently transfected with siNOX4 were unable to generate a migratory stimulus on MCF-7 cells. We also detected that NOX4 knockdown cells expressed lower levels of NOX4 at the protein level (measured by western blot) and a diminished capacity to generate intracellular ROS (Figure 3B and C).
Searching for a specific factor that regulates the RMF-EG-mediated stimulus on MCF-7 migration, we tested whether TGF-β1, a growth factor implicated in the control and expression of NOX in some cells (Murillo et al, 2007), was able to modulate the NOX4-dependent stimulus of RMF-EG cells. To test this hypothesis, RMF-EG cells were stimulated overnight with TGF-β1 (10 ng ml–1), previous to the onset of the cell migration assay. As Figure 4 shows, TGF-β1 pre-treated RMF-EG cells exhibit almost double effectiveness to stimulate MCF-7 migration. To test if a NOX activity is involved in the TGF-β1-dependent enhancement of epithelial migration, we incubated RMF-EG cells with 5 μ of DPI 30 min before pre-treatment with TGF-β1. Figure 4 also shows that DPI strongly inhibited TGF-β1 stimulus on MCF-7 migration. It is important to note that neither TGF-β1 nor DPI were present during the migration assay. Finally, to test if the signalling route activated by the factor is implicated in this effect, we performed a migratory assay using RMF-EG cells expressing a dominant-negative version of the TβR1. As Figure 4 shows, these mutant cells are unable to stimulate MCF-7 migration, indicating that the integrity of the TGF-β1-dependent signalling route is a requisite for the stimulus on MCF-7 migration.
To analyse whether the effects of stromal NOX4 and TGF-β1 activity stimulating MCF-7 cell migration are functionally linked, we studied the effect of TGF-β1 on NOX4 expression in RMF-EG mammary stromal cells. To do this, we incubated RMF-EG cells for 24 h with different concentrations of TGF-β1 and evaluated the NOX4 expression by real-time PCR. As shown in Figure 5A, TGF-β1 exerts a dose-response stimulus on NOX4 mRNA expression in the whole range of concentrations evaluated. The same treatment induces a linear enhancement on NOX4 protein and ROS production, evaluated by measuring the intracellular ROS content by cell fluorescence after loading with DCDHF-DA (Figure 5B and C).
To analyse whether TGF-β1, a component of the medium conditioned by mammary cells, is responsible of the enhanced expression of NOX4 in RMF-EG cells, we stimulated NOX4 expression by culturing stromal cells with medium conditioned (CM) by weakly (MCF-7) and strongly invasive (MDA-MB 231) human mammary cell lines that express and secrete a level of TGF-β1 proportional with their invasive potential, as we have recently demonstrated (Guerrero et al, 2010). To identify the contribution of TGF-β1 to NOX4 expression, we incubated RMF-EG cells in the presence or the absence of SB431542, a potent inhibitor of TβRI kinase activity that causes a blockage of Smad2/3 signalling route (Inman et al, 2002). As is shown in Figure 6, the expression of NOX4 mRNA, evaluated by real-time PCR, was stimulated by CMs of mammary cells in a magnitude that is proportional to its invasive potential that, in turn, is directly proportional with their TGF-β1 content. SB431542 completely inhibited the stimulus of CMs, suggesting that TGF-β1 is the major component of the soluble factors generated by mammary cells that stimulate NOX4 expression.
Cancer is one of the recognised pathologies whose progression has been associated with oxidative stress (Szatrowski and Nathan, 1991). The role of ROS in the initiation, promotion and progression of cancer involves their effects on cell replication, angiogenesis, apoptosis and migration (Halliwell, 2007). Previous data from our group and others have emphasised the importance of the redox balance in the acquisition of a malignant behaviour. These findings confirm the importance of endogenous generation of ROS by members of the NOX family and the regulatory role of the small GTPase Rac 1 in the epithelial migration (Kumar et al, 2008; Tobar et al, 2008).
Extensive evidence has been generated underscoring the relevance of the stroma in carcinogenesis (Radisky and Radisky, 2007). Recent data using a murine model highlight the importance of the stromal component on mammary tumourigenesis. These researchers have shown that Pten genetic ablation in mammary stromal fibroblasts cause ECM remodelling, recruitment of innate immune cells and an acceleration of the initiation, progression and malignant transformation of mammary epithelial tumours (Trimboli et al, 2009). In many other examples, tumour cells induce the production of inflammatory mediators that generate a chronic condition that supports the establishment of paracrine signalling that stimulates epithelial tumoral progression (Spaeth et al, 2008). Under this persistent inflammatory condition, it is easily expected that the tissue redox balance will be affected mainly by the production of ROS by non-epithelial cells under cancer cell stimulus (Benz and Yau, 2008).
Our results suggest that, under the stimulus of soluble factors secreted by MCF-7 mammary epithelial cells, RMF-EG mammary stromal cells modulate their own oxidative status by increasing the expression of NOX4, an enzymatic complex that has a relevant signalling function in mammary cells (Mahadev et al, 2004). Stromal NOX expression was able to stimulate the migratory capacity of MCF-7 cells as we have demonstrated using the siRNA strategy to knock down the expression of NOX4 (Figure 3A–C). These results emphasise the importance of a redox threshold in stromal cells needed to sustain a stimulus for epithelial cell migration. It has been demonstrated that in non-phagocytic cells, NOX4 is predominantly localised to the endoplasmic reticulum where it regulates the activity of protein tyrosine phosphatase 1B (Chen et al, 2008). We propose that, as a consequence of NOX4 activity, one (or several) signalling molecule(s) is generated by stromal cells to modulate, in a paracrine manner, epithelial migration. This property seems to be distinctive of tumoral cells because the MCF-10 cell line, which represents a non-tumoral counterpart of MCF-7 cell line, does not respond to the stromal stimulus. Transwell migration experiments performed in MCF-7 cells in the presence of catalase allowed us to rule out the participation of diffusible forms of ROS as part of the migratory stimulus (Figure 1B).
In a previous work, we analysed by immunohistochemistry the presence of TGF-β1 in samples of human ductal infiltrant mammary tumours. We found that this factor, which had an important role in the inhibition of the expression of adipogenic transcription factors, was expressed only by tumoral cells located at the invasive front, without a relevant expression in stromal adipose cells (Guerrero et al, 2010). In our experimental model, TGF-β1 exerts its pro-migratory stimulus through the stromal compartment by a phenomenon that is abolished by pre-treatment with DPI, that is, it depends on NOX activity (Figure 4). Besides this NOX-mediated migration stimulated by TGF-β1, the results in Figure 5 also show that NOX4 expression is induced by TGF-β1. Therefore, TGF-β1 action in this co-culture system may be explained by two simultaneous mechanisms: the NOX-dependent production of a soluble factor that stimulates MCF-7 migration and the enhancement of NOX4 expression by TGF-β1. Thus, the generation of a stromal intracellular oxidative environment by epithelial TGF-β1 can originate a positive feedback loop that further stimulates the production of soluble factor(s) that favour epithelial cell migration. This finding suggests a new mechanism for tumoral malignancy that may complement the well-known effect of epithelial oxidative environment in the acquisition of cellular migratory capacity (Kumar et al, 2008). Furthermore, stromal NOX4 seems to be a molecular target of TGF-β1 present in media conditioned by breast carcinoma cell lines, as was confirmed by the use of the TβRI inhibitor SB431542 that totally abolished the expression of NOX4 stimulated by media conditioned by MCF-7 and by MDA MB-231 cells, a more invasive cell line that secretes four times more TGF-β1 than MCF-7 (Guerrero et al, 2010).
TGF-β1 has been shown to increase the expression of NOX4 in different types of cells, although the localisation of NOX4 is still under debate. In fetal rat hepatocytes, this growth factor increased NOX4 expression as a part of a factor-induced apoptotic programme (Murillo et al, 2007). Also, it has been identified that ROS production in human hepatocyte cell lines previously infected with hepatitis C virus depends on NOX4 activity whose expression is, in turn, stimulated by TGF-β1 (Boudreau et al, 2009). More recently, it has been demonstrated in murine fibroblasts that the TGF-β1-stimulated expression of NOX4 results in the MAPK phosphatase-1 (MKP-1) oxidation, which is directly responsible for the factor-dependent modulation of gene expression (Liu et al, 2010). Our current effort is oriented to identify the specific molecular target whose oxidative condition is modified by NOX4, which would be responsible for the stromal stimulus to epithelial migration.
Collectively, the results presented herein emphasise a role for the stroma in the establishment of the patho-physiological conditions that support epithelial malignancy. Our proposal highlights the importance of the generation of an oxidative tumoral environment that favours epithelial motility and contributes, in this manner, to the expression of the malignant phenotype. Stromal NOX4-derived ROS that has been implicated in a variety of physiological processes (Brown and Griendling, 2009) may represent a potential target to prevent the acquisition of malignant properties by the epithelial compartment.
This work was supported by the grant (1080196 to JM) from the Fondo Nacional de Ciencia y Tecnología (FONDECYT) of Chile. We thank Dr Isabel Fabregat (Centre d'Oncologia Molecular (COM), IDIBELL-Institut d'Investigació Biomèdica de Bellvitge, L'Hospitalet, Barcelona, Spain) and Dr Mariana Cifuentes (INTA) for their critical reading of the manuscript.
The authors declare no conflict of interest.
|Benhar M,Dalyot I,Engelberg D,Levitzki A. Year: 2001Enhanced ROS production in oncogenically transformed cells potentiates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase activation and sensitization to genotoxic stressMol Cell Biol206913692610958687|
|Benz CC,Yau C. Year: 2008Ageing, oxidative stress and cancer: paradigms in parallaxNat Rev Cancer887587918948997|
|Blanchetot C,Boonstra J. Year: 2008The ROS-NOX connection in cancer and angiogenesisCrit Rev Eukaryot Gene Expr18354518197784|
|Boudreau HE,Emerson SU,Korzeniowska A,Jendrysik MA,Leto TL. Year: 2009Hepatitis C virus (HCV) proteins induce NADPH oxidase 4 expression in a transforming growth factor beta-dependent manner: a new contributor to HCV-induced oxidative stressJ Virol83129341294619812163|
|Brown DI,Griendling KK. Year: 2009Nox proteins in signal transductionFree Radic Biol Med471239125319628035|
|Carmona-Cuenca I,Roncero C,Sancho P,Caja L,Fausto N,Fernández M,Fabregat I. Year: 2008Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activityJ Hepatol4996597618845355|
|Chen K,Kirber MT,Xiao H,Yang Y,Keaney JF Jr. Year: 2008Regulation of ROS signal transduction by NADPH oxidase 4 localizationJ Cell Biol1811129113918573911|
|Cheng G,Cao Z,Xu X,van Meir EG,Lambeth JD. Year: 2001Homologs of gp91phox: cloning and tissue expression of Nox3, Nox4, and Nox5Gene26913114011376945|
|Coussens LM,Werb Z. Year: 2002Inflammation and cancerNature42086086712490959|
|De Wever O,Mareel M. Year: 2003Role of tissue stroma in cancer cell invasionJ Pathol20042944712845611|
|Dröge W. Year: 2002Free radicals in the physiological control of cell functionPhysiol Rev82479511773609|
|Egeblad M,Littlepage LE,Werb Z. Year: 2005The fibroblastic coconspirator in cancer progressionCold Spring Harb Symp Quant Biol7038338816869775|
|Elenbaas B,Weinberg RA. Year: 2001Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formationExp Cell Res64169184|
|Guerrero J,Tobar N,Cáceres M,Espinoza L,Escobar P,Dotor J,Smith PC,Martínez J. Year: 2010Soluble factors derived from tumor mammary cell lines induce a stromal mammary adipose reversion in human and mice adipose cells. Possible role of TGF-beta1 and TNF-alphaBreast Cancer Res Treat11949750819649705|
|Halliwell B. Year: 2007Oxidative stress and cancer: have we moved forwardBiochem J40111117150040|
|Inman GJ,Nicolas FJ,Callahan JF,Harling JD,Gaster LM,Reith AD,Laping NJ,Hill CS. Year: 2002SB-431542 is a potent and specific inhibitor of transforming growth factor-h superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7Mol Pharmacol,62657412065756|
|Kumar B,Koul S,Khandrika L,Meacham RB,Koul HK. Year: 2008Oxidative stress is inherent in prostate cancer cells and is required for aggressive phenotypeCancer Res681777178518339858|
|Kuperwasser C,Chavarria T,Wu M,Magrane G,Gray JW,Carey L,Richardson A,Weinberg RA. Year: 2004Reconstruction of functionally normal and malignant human breast tissues in miceProc Natl Acad Sci USA10149664971|
|Liu RM,Choi J,Wu JH,Gaston-Pravia KA,Lewis KM,Brand JD,Reyes Mochel NS,Krzywanski DM,Lambeth JD,Hagood JS,Forman HJ,Thannickal VJ,Postlethwait EM. Year: 2010Oxidative modification of nuclear mitogen activated protein kinase phosphatase 1 is involved in transforming growth factor beta1-induced expression of plasminogen activator inhibitor 1 in fibroblastsJ Biol Chem285162391624720228065|
|Mahadev K,Motoshima H,Wu X,Ruddy JM,Arnold RS,Cheng G,Lambeth JD,Goldstein BJ. Year: 2004The NAD(P)H oxidase homolog Nox4 modulates insulin-stimulated generation of H2O2 and plays an integral role in insulin signal transductionMol Cell Biol241844185414966267|
|Murillo MM,Carmona-Cuenca I,Del Castillo G,Ortiz C,Roncero C,Sánchez A,Fernández M,Fabregat I. Year: 2007Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanismBiochem J40525125917407446|
|Ostman A,Augsten M. Year: 2009Cancer-associated fibroblasts and tumor growth--bystanders turning into key playersCurr Opin Genet Dev19677319211240|
|Radisky ES,Radisky DC. Year: 2007Stromal induction of breast cancer: inflammation and invasionRev Endocr Metab Disord827928717447144|
|Ranjan P,Anathy V,Burch PM,Weirather K,Lambeth JD,Heintz NH. Year: 2006Redox-dependent expression of cyclin D1 and cell proliferation by Nox1 in mouse lung epithelial cellsAntioxid Redox Signal81447145916987002|
|Spaeth E,Klopp A,Dembinski J,Andreeff M,Marini F. Year: 2008Inflammation and tumor microenvironments: defining the migratory itinerary of mesenchymal stem cellsGene Therapy1573073818401438|
|Szatrowski TP,Nathan CF. Year: 1991Production of large amounts of hydrogen peroxide by human tumor cellsCancer Res517947981846317|
|Tobar N,Cáceres M,Santibáñez JF,Smith PC,Martínez J. Year: 2008RAC1 activity and intracellular ROS modulate the migratory potential of MCF-7 cells through a NADPH oxidase and NFkappaB-dependent mechanismCancer Lett26712513218433991|
|Trimboli AJ,Cantemir-Stone CZ,Li F,Wallace JA,Merchant A,Creasap N,Thompson JC,Caserta E,Wang H,Chong JL,Naidu S,Wei G,Sharma SM,Stephens JA,Fernandez SA,Gurcan MN,Weinstein MB,Barsky SH,Yee L,Rosol TJ,Stromberg PC,Robinson ML,Pepin F,Hallett M,Park M,Ostrowski MC,Leone G. Year: 2009Pten in stromal fibroblasts suppresses mammary epithelial tumoursNature4611084109319847259|
|Ushio-Fukai M,Nakamura Y. Year: 2008Reactive oxygen species and angiogenesis: NADPH oxidase as target for cancer therapyCancer Lett266375218406051|
Keywords: NOX4, ROS, migration, breast cancer, stroma.
Previous Document: Inactivation of the WASF3 gene in prostate cancer cells leads to suppression of tumorigenicity and m...
Next Document: In vitro antitrypanosomal activity of 12 low-molecular-weight antibiotics and observations of struct...